Drug
E7050
E7050: highest development phase Phase 1, developed by Eisai. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Eisai
Trials
| Drug | Phase | Indication |
|---|---|---|
| E7050 NCT02533102 | Phase 1 | Healthy Subjects |
Latest
No recent events.
Follow E7050 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.